Regulatory News


This section of is devoted to news about worldwide regulatory and legal changes affecting the head lice industry.

15.12.17 | Prevalence of Pediculus capitis in school children in Battambang, Cambodia

A new study investigating head lice prevalence in Cambodia has found an overall prevalence rate of 44.3% among school children living in the Battambang.

14.10.16 | FDA Finalises Head Lice Guidance

In an effort to control the head lice infestations and drug resistance to the most commonly used head lice treatments, the US Food and Drug Administration (FDA) has issued a new guidance on developing topical drugs.

05.06.14 | FTC fines head lice company for misleading claims

The Federal Trade Commission has fined the manufacturer of Lice Shield $0.5M for misleading advertising claims.

31.10.13 | Best Yet! head-lice marketing requires FDA pre-approval

A recent decision by the US Federal Trade Commission (FTC) requires that advertising claims by makers of Best Yet! head lice products receive Food and Drug Administration (FDA) pre-approval.

13.12.12 | FDA rejects lindane ban petition

A petition requesting that lindane be withdrawn from sale as a second-line pediculicide has been denied by the US Food and Drug Administration (FDA).

28.09.12 | FDA Updates requirements for Medical Device Registration

The US Food and Drug Administration (FDA) is introducing new requirements and responsibilities for the registration and listing of Medical Devices, effective October 1, 2012. 

13.06.12 | FDA urged to halt lindane use

The US Food and Drug Administration (FDA) have been urged to prevent the use of lindane in topical pediculosis treatments for children.

27.03.12 | Updated UK Head Lice Treatment Guidelines

The Public Health Medicine Environmental Group (PHMEG) has recently released updated guidelines for diagnosis, preventation and treatment of head lice infection. This is a revised version of the 2008 update.

08.02.12 | FDA grants approval to Sanofi-Topaz Sklice treatment

The FDA have granted approval on Tuesday 7 February 2012 to Sklice® lotion, the ivermectin-based topical treatment produced by Topaz Pharmaceuticals, now part of Sanofi Pasteur US.

Join us on Twitter

Site Map   |    Privacy Policy   |   Terms & Conditions

© 2012-2013 — all rights reserved